| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |